$17.13
+0.52 (+3.13%)
Open$16.98
Previous Close$16.61
Day High$17.37
Day Low$16.79
52W High$22.51
52W Low$14.14
Volume—
Avg Volume91.0K
Market Cap216.27M
P/E Ratio—
EPS$-1.90
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+127.3% upside
Current
$17.13
$17.13
Target
$38.94
$38.94
$25.16
$38.94 avg
$46.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 26.03M | 27.47M | 84.88M |
| Net Income | -38,903,480 | -36,945,375 | 12.73M |
| Profit Margin | -149.5% | -142.0% | 15.0% |
| EBITDA | -39,657,294 | -39,753,539 | 16.15M |
| Free Cash Flow | — | — | 13.25M |
| Rev Growth | -5.2% | -5.2% | +19.4% |
| Debt/Equity | 0.22 | 0.22 | 1.84 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |